Hostname: page-component-599cfd5f84-v8j7l Total loading time: 0 Render date: 2025-01-07T06:24:02.041Z Has data issue: false hasContentIssue false
  • English
  • Français

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users

Published online by Cambridge University Press:  17 May 2006

J. AMIN ,
M. G. LAW ,
J. MICALLEF ,
M. JAUNCEY ,
I. VAN BEEK ,
J. M. KALDOR  and
G. J. DORE
J. AMIN
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
M. G. LAW
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
J. MICALLEF
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
M. JAUNCEY
Affiliation:
Public Health Officer Training Scheme, NSW Health, Sydney, Australia
I. VAN BEEK
Affiliation:
Kirketon Road Centre, Sydney, Australia
J. M. KALDOR
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
G. J. DORE
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Estimates of hepatitis C virus (HCV) clearance following acute infection range from 14 to 46%. This wide range is likely to be due to the characteristics of the populations studied and analysis methods. This paper examines how differing definitions of clearance parameters affect estimates of viral clearance in a cohort of 85 injecting drug users with newly acquired HCV infection. Kaplan–Meier estimates of time to HCV clearance were determined using varying definitions of eligible cohort, viral clearance, date of infection and date of clearance. Based on which combinations of definitions were used, the number of subjects eligible for analysis ranged from 27 to 75, clearance rate ranged from 14 to 68% and time to achieving 25% clearance ranged from approximately 5 months to 14 months. Standardized definitions and methodologies are required to enable valid comparisons of rates of clearance across newly acquired HCV infection natural history studies.

Type
Research Article
Information
Epidemiology & Infection , Volume 135 , Issue 1 , January 2007 , pp. 144 - 150
Copyright
© 2006 Cambridge University Press